Evelyn Toh1, Xiang Gao2, James A Williams3, Teresa A Batteiger3, Lisa A Coss3, Michelle LaPradd4, Jie Ren4, William M Geisler5, Yue Xing6, Qunfeng Dong, David E Nelson1, Stephen J Jordan. 1. From the Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN. 2. Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL. 3. Departments of Medicine. 4. Biostatistics, Indiana University School of Medicine, Indianapolis, IN. 5. Department of Medicine, University of Alabama at Birmingham, Birmingham, AL. 6. Center for Biomedical Informatics, Stritch School of Medicine, Loyola University Chicago, Maywood, IL.
Abstract
BACKGROUND: In men with nongonococcal urethritis (NGU), clinicians and patients rely on clinical cure to guide the need for additional testing/treatment and when to resume sex, respectively; however, discordant clinical and microbiological cure outcomes do occur. How accurately clinical cure reflects microbiological cure in specific sexually transmitted infections (STIs) is unclear. METHODS: Men with NGU were tested for Neisseria gonorrhoeae, Chlamydia trachomatis (CT), Mycoplasma genitalium (MG), Trichomonas vaginalis, urethrotropic Neisseria meningitidis ST-11 clade strains, and Ureaplasma urealyticum (UU). Men received azithromycin 1 g and returned for a 1-month test-of-cure visit. In MG infections, we evaluated for the presence of macrolide resistance-mediating mutations (MRMs) and investigated alternate hypotheses for microbiological treatment failure using in situ shotgun metagenomic sequencing, phylogenetic analysis, multilocus sequence typing analyses, and quantitative PCR. RESULTS: Of 280 men with NGU, 121 were included in this analysis. In the monoinfection group, 52 had CT, 16 had MG, 7 had UU, 10 had mixed infection, and 36 men had idiopathic NGU. Clinical cure rates were 85% for CT, 100% for UU, 50% for MG, and 67% for idiopathic NGU. Clinical cure accurately predicted microbiological cure for all STIs, except MG. Discordant results were significantly associated with MG-NGU and predominantly reflected microbiological failure in men with clinical cure. Mycoplasma genitalium MRMs, but not MG load or strain, were strongly associated with microbiological failure. CONCLUSIONS: In azithromycin-treated NGU, clinical cure predicts microbiological cure for all STIs, except MG. Nongonococcal urethritis management should include MG testing and confirmation of microbiological cure in azithromycin-treated MG-NGU when MRM testing is unavailable.
BACKGROUND: In men with nongonococcal urethritis (NGU), clinicians and patients rely on clinical cure to guide the need for additional testing/treatment and when to resume sex, respectively; however, discordant clinical and microbiological cure outcomes do occur. How accurately clinical cure reflects microbiological cure in specific sexually transmitted infections (STIs) is unclear. METHODS: Men with NGU were tested for Neisseria gonorrhoeae, Chlamydia trachomatis (CT), Mycoplasma genitalium (MG), Trichomonas vaginalis, urethrotropic Neisseria meningitidis ST-11 clade strains, and Ureaplasma urealyticum (UU). Men received azithromycin 1 g and returned for a 1-month test-of-cure visit. In MG infections, we evaluated for the presence of macrolide resistance-mediating mutations (MRMs) and investigated alternate hypotheses for microbiological treatment failure using in situ shotgun metagenomic sequencing, phylogenetic analysis, multilocus sequence typing analyses, and quantitative PCR. RESULTS: Of 280 men with NGU, 121 were included in this analysis. In the monoinfection group, 52 had CT, 16 had MG, 7 had UU, 10 had mixed infection, and 36 men had idiopathic NGU. Clinical cure rates were 85% for CT, 100% for UU, 50% for MG, and 67% for idiopathic NGU. Clinical cure accurately predicted microbiological cure for all STIs, except MG. Discordant results were significantly associated with MG-NGU and predominantly reflected microbiological failure in men with clinical cure. Mycoplasma genitalium MRMs, but not MG load or strain, were strongly associated with microbiological failure. CONCLUSIONS: In azithromycin-treated NGU, clinical cure predicts microbiological cure for all STIs, except MG. Nongonococcal urethritis management should include MG testing and confirmation of microbiological cure in azithromycin-treated MG-NGU when MRM testing is unavailable.
Authors: J R Schwebke; A Rompalo; S Taylor; A C Seña; D H Martin; L M Lopez; S Lensing; J Y Lee Journal: Clin Infect Dis Date: 2011-01-15 Impact factor: 9.079
Authors: Catherine M Wetmore; Lisa E Manhart; M Sylvan Lowens; Matthew R Golden; William L H Whittington; Ana Maria Xet-Mull; Sabina G Astete; Nicole L McFarland; Sarah J McDougal; Patricia A Totten Journal: Sex Transm Dis Date: 2011-03 Impact factor: 2.830
Authors: Arlene C Seña; Shelly Lensing; Anne Rompalo; Stephanie N Taylor; David H Martin; Laureen M Lopez; Jeannette Y Lee; Jane R Schwebke Journal: J Infect Dis Date: 2012-05-21 Impact factor: 5.226
Authors: Sarah S Romano; Jørgen S Jensen; M Sylvan Lowens; Jennifer L Morgan; Laura C Chambers; Tashina S Robinson; Patricia A Totten; Olusegun O Soge; Matthew R Golden; Lisa E Manhart Journal: Clin Infect Dis Date: 2019-06-18 Impact factor: 9.079
Authors: Maria Frølund; Peter Lidbrink; Arne Wikström; Susan Cowan; Peter Ahrens; Jørgen Skov Jensen Journal: Acta Derm Venereol Date: 2016-06-15 Impact factor: 4.437
Authors: Lisa E Manhart; Jørgen Skov Jensen; Catriona S Bradshaw; Matthew R Golden; David H Martin Journal: Clin Infect Dis Date: 2015-12-15 Impact factor: 9.079
Authors: Laura H Bachmann; Lisa E Manhart; David H Martin; Arlene C Seña; Jordan Dimitrakoff; Jørgen Skov Jensen; Charlotte A Gaydos Journal: Clin Infect Dis Date: 2015-12-15 Impact factor: 9.079